Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABAA receptor subtypes
- 4 September 2002
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 451 (2) , 103-110
- https://doi.org/10.1016/s0014-2999(02)02191-x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Changes in GABAA receptor gene expression induced by withdrawal of, but not by long-term exposure to, zaleplon or zolpidemNeuropharmacology, 2002
- Molecular and Neuronal Substrate for the Selective Attenuation of AnxietyScience, 2000
- Novel 2-Phenylimidazo[1,2-a]pyridine Derivatives as Potent and Selective Ligands for Peripheral Benzodiazepine Receptors: Synthesis, Binding Affinity, and in Vivo StudiesJournal of Medicinal Chemistry, 1999
- 2‐Phenyl‐imidazo[1,2‐a]pyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action in ratsBritish Journal of Pharmacology, 1999
- A Review of the Preclinical Development of Zaleplon, a Novel Non‐Benzodiazepine Hypnotic for the Treatment of InsomniaCNS Drug Reviews, 1997
- GABAA Receptors Containing the α4‐Subunit: Prevalence, Distribution, Pharmacology, and Subunit Architecture In SituJournal of Neurochemistry, 1997
- Which GABAA-receptor subtypes really occur in the brain?Trends in Neurosciences, 1996
- A rapid screening method for the assessment of benzodiazepine receptor-related physical dependence in mice: Evaluation of benzodiazepine-related agonists and partial agonistsJournal of Pharmacological Methods, 1991
- ZolpidemDrugs, 1990
- Importance of a novel GABAA receptor subunit for benzodiazepine pharmacologyNature, 1989